Institutional investors control 49.47% of the outstanding shares in ANTH. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2013, these large investors purchased a net $355.3 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAMBER CAPITAL MANAGEMENT LLC Bought 350.0 Thousand shares of Anthera Pharmaceuticals I...
FRANKLIN ADVISERS, INC. Bought 260.3 Thousand shares of Anthera Pharmaceuticals I...